# Protagenic Therapeutics, Inc.\\new: Form 8-K, filed Aug 22, 2025

- Company: [Protagenic Therapeutics, Inc.\\new](/companies/ptix.md) (CIK 1022899)
- Form: 8-K
- Filed: 2025-08-22
- Accepted by EDGAR: Aug 22, 2025, 17:28 ET
- Period: 2025-08-07
- Accession: 0001641172-25-025274
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1022899/000164117225025274/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1022899/000164117225025274/

## Items reported

- Item 3.01: Delisting notice
- Item 4.01: Change of auditor
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1022899/000164117225025274/form8-k.htm

Filed Aug 22, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-025274. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.
